Saltar al contenido
Merck

Noggin regulates foregut progenitor cell programming, and misexpression leads to esophageal atresia.

The Journal of clinical investigation (2020-05-20)
Carolina Pinzon-Guzman, Sreedhara Sangadala, Katherine M Riera, Evgenya Y Popova, Elizabeth Manning, Won Jae Huh, Matthew S Alexander, Julia S Shelton, Scott D Boden, James R Goldenring
RESUMEN

Esophageal atresia (EA/TEF) is a common congenital abnormality present in 1 of 4000 births. Here we show that atretic esophagi lack Noggin (NOG) expression, resulting in immature esophagus that contains respiratory glands. Moreover, when using mouse esophageal organoid units (EOUs) or tracheal organoid units (TOUs) as a model of foregut development and differentiation in vitro, NOG determines whether foregut progenitors differentiate toward esophageal or tracheal epithelium. These results indicate that NOG is a critical regulator of cell fate decisions between esophageal and pulmonary morphogenesis, and its lack of expression results in EA/TEF.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Cóctel de inhibidores de proteasas, for use with mammalian cell and tissue extracts, DMSO solution
Sigma-Aldrich
Phosphatase Inhibitor Cocktail 2, aqueous solution (dark coloration may develop upon storage, which does not affect the activity)
Sigma-Aldrich
Cóctel de inhibidores de fosfatasa 3, DMSO solution
Sigma-Aldrich
Anti-Nkx2.1 Antibody, clone 8G7-G3-1, ascites fluid, clone 8G7-G3-1, Chemicon®
Sigma-Aldrich
Anti-SHH Antibody, clone 5H4, clone 5H4, from mouse